## Abstract Purified viruses, viral antigens, and cell extracts have been tested for their ability to stimulate protein synthesis by MSV‐M^1^ regressor spleen cells from BALB/c mice. Immune, but not normal cells, responded to MSV‐M, but not to MSV‐G virus^1^, and to the type‐specific viral envelope
Cell-mediated immunity to Moloney sarcoma virus in mice. II. Analysis of antigenic specificities involved in T lymphocyte-mediated in vivo rejection of murine sarcoma virus-induced tumors
✍ Scribed by R. M. Gorczynski; R. A. Knight
- Publisher
- John Wiley and Sons
- Year
- 1975
- Tongue
- English
- Weight
- 814 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Sublethally irradiated BALB/c mice innoculated with Moloney sarcoma virus (MSV‐M) develop progressively growing tumors and die within 30 days of virus innoculation. These animals can be protected from tumor progression (and death) by innoculation of small numbers of MSV‐immune T lymphocytes from MSV‐M innoculated (but unirradiated) animals. T lymphocytes in these donor animals have been shown to express immunity to a variety of viral and virallyinduced antigens. We have investigated whether immunity to any one of these antigens was critically important in leading to protection of the irradiated animals by sesitizing normal T lymphocytes in vitro to different viral antigens and examining the ability of these sensitized cells to protect the irradiated recipients. Data is presented to show that cells sensitized in vitro to MSV‐transformed fibroblasts, and to purified antigens with group specificity, but not to viral envelope antigens, or whole virus, are capable of protecting the irradiated MSV innoculated animals.
📜 SIMILAR VOLUMES
## Abstract Quantitative studies using a ^51^Cr release assay were performed to analyse the time‐course of appearance and specificity of cytolytic cells in C57BI/6 mice inoculated with Moloney murine sarcoma virus (MSV). Various lymphoid organs were studied including spleen, mesenteric lymph nodes
It was shown previously that B6.C-H-Zbm" (bm14) mice, carrying a mutation in the H-2Db locus, are unable to generate cytotoxic T cells (CTL) against Moloney murine sarcoma virus (M-MSV). We now report an analysis of tumor induction and regression kinetics and of immunity to the virus, following the
## Abstract Murine sarcoma virus (MSV)‐induced transformed tumor cells, which are releasers and non‐releasers of virus, were investigated by transplantation immunity and a variety of serological assays. Transplantation immunity demonstrated that tumor‐associated transplantation antigens could be de
## Abstract Anti‐tumour cell‐mediated immune reactions were studied by the chromium release test (CRT) in mice bearing autochtonous Murine Sarcoma Virus (MSV)‐induced sarcomas or syngeneic transplants of lymphomas with various antigenic specificities. Cytotoxic lymphoid cells were detected during t